Membranous Nephropathy and Nonsteroidal Anti-inflammatory Agents
Authors:
- Christopher P. LarsenCLChristopher P. Larsen
- Megan L. TroxellMTMegan L. Troxell
- 1 November 2013
- journal article
- case report
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 62 (5) , 1012-1017
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsiesLaboratory Investigation, 2013
- Absence of glomerular IgG4 deposition in patients with membranous nephropathy may indicate malignancyNephrology Dialysis Transplantation, 2011
- Anti-Phospholipase A2 Receptor Antibody in Membranous NephropathyJournal of the American Society of Nephrology, 2011
- Safe Administration of Celecoxib to a Patient with Repeated Episodes of Nephrotic Syndrome Induced by NSAIDsClinical Drug Investigation, 2011
- M-Type Phospholipase A2Receptor as Target Antigen in Idiopathic Membranous NephropathyNew England Journal of Medicine, 2009
- Membranous Nephropathy Associated with the Relatively Selective Cyclooxygenase-2 Inhibitor, Etodolac, in a Patient with Early Rheumatoid ArthritisInternal Medicine, 2007
- Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration RateAnnals of Internal Medicine, 2006
- Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathyNephrology Dialysis Transplantation, 2004
- Membranous glomerulopathy and acute interstitial nephritis following treatment with celecoxibClinical Nephrology, 2003
- Membranous Nephropathy Associated with Oxaprozin TreatmentNephron, 1996